Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Hypoaesthesia, Impaired work ability, Inappropriate schedule of product administration, Loss of personal independence in daily activities, Lumbar puncture abnormal
Clinical narrative: Multiple Sclerosis/autoimmune disorder/partial facial paralysis/partial body numbness, and horizontal nystagmus came back in full force/vertigo; migraine; first dosage on March 21, 2022/second dosage on April 20, 2022.; Bell's Palsy/right-side facial numbness/facial paralysis; hearing loss; Information has been received regarding a case in litigation from a lawyer and referred to an adult female patient (pt) of unspecified age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. Before the Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) vaccine, the pt was a normal, healthy person and able to do typical daily activities. She played the flute, piano, and guitar. She was in college for graphic design, and pursuing a career as a tattoo artist. On 21-MAR-2022 (when the pt was 22-year-old), and 20-APR-2022, she was vaccinated with the first and second dosages of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) intramuscular injection (both strength, dose, route, lot# and expiration date were not reported) for preventing cervical cancer, in light of the pt's doctor's recommendations (Inappropriate schedule of product administration). Within three months of receiving the second Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) dose (considered unknown date in 2022), the pt experienced right-side facial numbness, hearing loss and facial paralysis. She sought treatment at an emergency care where she was diagnosed with Bell's Palsy. Days after her visit, the pt experienced complete numbness on the left side of her body, and horizontal nystagmus in her right eye. She was unable to eat and speak correctly, and her ability to walk was declining. She began to need assistance with simple tasks such as going to the bathroom. After three weeks of medication, her symptoms began to lift and she traveled home. Two days after arriving home, the pt's partial facial paralysis, partial body numbness, and horizontal nystagmus came back in full force. She sought emergency care at a medical center, where she was admitted for further testing. The pt was diagnosed with multiple sclerosis (consider hospitalized due to this event in 2022) through a lumbar puncture and Magnetic Resonance Imaging (MRI) in September 2022. In May 2023, she started her Disease Modifying Therapy, ofatumumab (KESIMPTA). Since her initial diagnosis, doctors had found a new lesion in addition to the eight lesions she was originally diagnosed with. She would remain on treatment for the rest of her life to slow the progression of her disease. As a result of her post-vaccine symptoms which now included daily hand tremors, slurred speech, numbness in various parts of her body, weakness in her arms and legs, twitches in her eye, vertigo, and migraines (onset date unknown), the pt had been unable to engage in normal activities that a normal young person would enjoy. Post the vaccine, the pt was unable to play instruments or draw. The pt's social skills had declined due to her brain fog, comprehension, and memory struggles, and her speech was slurred making her difficult to understand. This made her ability to work a full-time job to provide for herself and medical expenses increasingly difficult. She was unable to become a mother, as childbirth could cause a flare-up from which she might not recover. This disease had drastically altered her quality of life, dreams of motherhood, career ambitions, and the simple joy of creating art and playing an instrument. The pt contended that her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injections caused her to develop multiple sclerosis, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which were alleged herein and all of which were caused by the vaccine or otherwise linked to her vaccine-induced autoimmune and neurological disorder. As a proximate result of company's wrongful acts and omissions and its negligent and fraudulent testing, labeling, manufacturing, marketing and promotion of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), the pt had suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and had suffered severe and permanent emotional injuries, including pain and suffering. The pt also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL). As a direct and proximate result of her vaccine-induced injuries, the pt had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of all events (except for the marker code) was considered as not recovered. The causality assessment between all the events (except for the marker code) and Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) was considered as related by the lawyer.    All the events (except for the marker code) were considered to be disability by the lawyer. Upon on internal review, the events of Bell's palsy, hearing loss, and multiple sclerosis were considered to be medically significant.